Cabaletta Bio Inc

CABAStocksBiotechnologyUnited StatesNasdaqUSD

Price

$1.96

Today

-2.9%

YTD

-9.7%

About

Cabaletta Bio Inc is a distinguished player in the biotechnology world, developing cellular therapies for patients suffering from autoimmune diseases. The firm operates on a global level. Cabaletta Bio operates in the groundbreaking and fast-paced biotechnology industry. It is known for its innovative services, particularly its cellular therapies based on the revolutionary Chimeric AutoAntibody Receptor (CAAR) platform. While it is part of the larger community of biotech firms, it sets the tone in its unique domain of autoimmune diseases with its scientifically advanced approach. Expand your virtual portfolio by following CABA on eToro.

Price chart

Closing price history for CABA (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-1.31

P/S (TTM)0.00

P/B (TTM)1.66

Market cap$352.65M

Cap tierSmall-cap

Industry avg P/E-1.91

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-93.20%

ROA-75.36%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$1.58

Free cash flow$-154.21M

Total debt$25.71M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.79

Employees156

Next earnings16 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.